Gerresheimer announced that it has acquired an exclusive license from West Pharmaceutical Services to complete its prefillable syringes portfolio with passive syringe safety solutions.
“As a result of our long-standing partnership with the leading manufacturer of packaging components and delivery devices for parenteral drugs, we are pleased to have acquired the rights to market this innovative, new syringe safety solution, developed by West,” said Uwe Röhrhoff, CEO of Gerresheimer. “By doing so, we will complement our very broad range of prefillable syringe solutions for biotech and other drugs.”
Get the full story on our sister site, Medical Design & Outsourcing.